Patent details

Basic Information

Publication number:

EP2295055

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP101860864

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof

French Title of Invention:

(+)-2-[1-(3-Ethoxy-4-méthoxyphényl)-2-méthylsulfonyléthyl]-4-acétylaminoisoindoline-1,3-dione: Ses procédés d'utilisation et compositions correspondantes

German Title of Invention:

(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindolin-1,3-dion: Verwendungsverfahren und Zusammensetzungen davon

SPC Number:

Dates

Filing date:

20/03/2003

Grant date:

07/06/2017

EP Publication Date:

16/03/2011

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/06/2017

EP B1 Publication Date:

07/06/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

20/03/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/05/2020

 

 

Name:

Amgen (Europe) GmbH

Address:

Floor 6-8 Suurstoffi 22, 6343 Risch-Rotkreuz, Switzerland (CH)

History of Owners

From:

07/06/2017

To:

08/05/2020

Name:

Celgene Corporation

Address:

86 Morris Avenue, Summit New Jersey 07901, United States (US)

Agent

Name:

VALIPAT

From:

07/08/2017

Address:

Uitbreidingstraat 72-5, 2600, Antwerp, Belgium (BE)

To:

Inventor

1

Name:

Man, Hon-Wah

Address:

United States (US)

2

Name:

Schafer, Peter H.

Address:

United States (US)

3

Name:

Ge, Chuansheng

Address:

United States (US)

4

Name:

Muller, George W.

Address:

United States (US)

Priority

1

Priority Number:

366515 P

Priority Date:

20/03/2002

Priority Country:

United States (US)

2

Priority Number:

438450 P

Priority Date:

07/01/2003

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/4035; A61P 37/00; C07C 317/28; C07D 209/48;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2020/07

Publication date:

12/06/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:

201723

Publication date:

07/06/2017

Description:

Grant (B1)

Deed

Power of attorney

Change Kind/ Decision Type:

Assignment

Deed Number:

RC20170000282A

Date Registered:

07/08/2017

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

VALIPAT

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20200000144A

Date Registered:

08/05/2020

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Amgen (Europe) GmbH

Address:

Floor 6-8 Suurstoffi 22, 6343 Risch-Rotkreuz, Switzerland (CH)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

17/02/2022

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
08/05/2020	Request For Change	114
25/05/2020	Outgoing Correspondence	2
10/08/2017	Outgoing Correspondence	1
07/08/2017	Request For Change	2